Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform
Go back to Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform| Xenetic Biosciences, Inc. (NASDAQ: XBIO) | Delayed: 2.94 +0.14 (5.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.80 | 52 Week High | $5.20 | |||
| Open | $2.76 | 52 Week Low | $0.21 | |||
| Day High | $2.94 | P/E | N/A | |||
| Day Low | $2.76 | EPS | $-0.01 | |||
| Volume | 11,254 | |||||
